[Dosage Form]

 Liquid for injection

[Specification] 

250 IU/vial, 1000 IU/vial

[Indication]

 This product is indicated for use in adults and adolescents (≥ 12 years) with hemophilia A (congenital factor VIII deficiency) for treatment and prophylaxis of bleeding episodes.

Administration: Intravenous injection

[Shelf Life]

 24 months